期刊文献+

Nonmetabolic functions of pyruvate kinase isoform M2 in controlling cell cycle progression and tumorigenesis 被引量:7

Nonmetabolic functions of pyruvate kinase isoform M2 in controlling cell cycle progression and tumorigenesis
下载PDF
导出
摘要 Pyruvate kinase catalyzes the rate-limiting final step of glycolysis, generating adenosine triphosphate (ATP) and pyruvate. The M2 tumor-specific isoform of pyruvate kinase (PKM2) promotes glucose uptake and lactate production in the presence of oxygen, known as aerobic glycolysis or the Warburg effect. As recently reported in Nature, PKM2, besides its metabolic function, has a nonmetabolic function in the direct control of cell cycle progression by activating β-catenin and inducing expression of the β-catenin downstream gene CCND1 (encoding for cyclin D1). This nonmetabolic function of PKM2 is essential for epidermal growth factor receptor (EGFR) activation-induced tumorigenesis. Pyruvate kinase catalyzes the rate-limiting final step of glycolysis, generating adenosine triphosphate (ATP) and pyruvate. The M2 tumor-specific isoform of pyruvate kinase (PKM2) promotes glucose uptake and lactate production in the presence of oxygen, known as aerobic glycolysis or the Warburg effect. As recently reported in Nature, PKM2, besides its metabolic function, has a nonmetabolic function in the direct control of cell cycle progression by activating β-catenin and inducing expression of the 15-catenin downstream gene CCND1 (encoding for cyclin D1). This nonmetabolic function of PKM2 is essential for epidermal growth factor receptor (EGFR) activation-induced tumorigenesis.
作者 Zhimin Lu
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2012年第1期5-7,共3页
关键词 丙酮酸激酶 周期进程 直接控制 肿瘤 亚型 细胞 表皮生长因子受体 CYCLIN Pyruvate kinase, cell cycle, tumorigenesis
  • 相关文献

参考文献19

  • 1Vander Heiden MG, Cantley LC, Thompson CB. Understandingthe Warburg effect: the metabolic requirements of cellproliferation. Science, 2009,324(5930):1029-1033.
  • 2Altenberg B, Greulich KO. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics, 2004,84 (6):1014-1020.
  • 3Majumder PK, Febbo PG, Bikoff R, et al. mTOR inhibitionreverses Ak-tdependent prostate intraepithelial neoplasia throughregulation of apoptotic and HIF-1 -dependent pathways . NatMed, 2004,10(6):594-601.
  • 4Jurica MS, Mesecar A, Heath PJ, et al. The allostericregulation of pyruvate kinase by fructose-1,6 -bisphosphate.Structure, 1998,6(2):195-210.
  • 5Mellati AA, Yucel M, Altinors N, et al. Regulation of M2 -typepyruvate kinase from human meningioma by allosteric effectorsfructose 1,6 diphosphate and L -alanine. Cancer BiochemBiophys, 1992,13(1):33-41.
  • 6Guminska M, Stachurska MB, Ignacak J. Pyruvate kinaseisoenzymes in chromatin extracts of Ehrlich ascites tumour,Morris hepatoma 7777 and normal mouse and rat livers.Biochim Biophys Acta, 1988,966(2):207-213.
  • 7Oremek GM, Teigelkamp S, Kramer W, et al. The pyruvatekinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker forrenal carcinoma. Anticancer Res, 1999,19(4A):2599-2601.
  • 8Christofk HR, Vander Heiden MG, Harris MH, et al. The M2splice isoform of pyruvate kinase is important for cancermetabolism and tumour growth. Nature, 2008,452 (7184):230-233.
  • 9Anastasiou D, Poulogiannis G, Asara JM, et al. Inhibition ofpyruvate kinase M2 by reactive oxygen species contributes tocellular antioxidant responses. Science, 2011,334 (6060):1278-1283.
  • 10Hitosugi T, Kang S, Vander Heiden MG, et al. Tyrosinephosphorylation inhibits PKM2 to promote the Warburg effectand tumor growth. Sci Signal, 2009,2(97):ra73.

同被引文献7

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部